Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin

NHS England

This public procurement record has 4 releases in its history.

Award

30 Jan 2026 at 09:48

UK7 - Contract Details Notice
Award

26 Nov 2025 at 15:36

UK6 - Contract Award Notice
Tender

02 Oct 2025 at 13:32

UK4 - Tender Notice
Planning

03 Sep 2025 at 15:37

UK2 - Preliminary Market Engagement Notice
Summary of the contracting process

The procurement process for the NHS National Transition Framework for Apremilast, Pazopanib, and Dapagliflozin was initiated by NHS England, located in London, UK. This procurement, classified under the pharmaceutical industry category, involves pharmaceutical products delivery across various regions within the United Kingdom. The process culminated in the award stage, with the contract awarded on 5th January 2026. This framework agreement, with a potential extension of up to 24 months at the authority's discretion, commenced on 1st February 2026 and is set to conclude by 30th September 2027. The agreement was an open procedure, allowing for broad access to the tender, emphasising transparency and competitive bidding.

Businesses participating in this procurement have the potential for growth by supplying high-demand pharmaceutical products to the NHS. The open procedure is particularly beneficial for companies in the pharmaceutical sector, both large enterprises and SMEs, as it provides an excellent opportunity to gain a foothold or expand presence within the public sector market. Suppliers like ZENTIVA PHARMA UK LIMITED and ACCORD-UK LTD have shown that both large and smaller companies can successfully compete and secure contracts, which suggests that diverse business sizes have competitive potential in such procurements.

How relevant is this notice?

Notice Information

Notice Title

NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin

Notice Description

Project title: NHS National Framework for Transition Products (Apremilast, Pazopanib and Dapagliflozin) commencing 1st February 2026 Offer reference number: CM/TNS/25/5735 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin Lot 1 DLN/DNW: 01/02/2026 to 31/01/2027 (12 months) Lot 2 DLS/DNE: 01/02/2026 to 31/01/2027 (12 months) Lot 3 DCE/DSW: 01/02/2026 to 30/09/2027 (20 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Lot Information

Lot 1

Renewal: Option or options to extend (at the discretion of the Authority) up to a maximum of 24 months

Planning Information

NHS England is seeking to engage with suppliers that are planning to launch any of the molecules that will be covered by this procurement. Interested suppliers will be invited to a virtual preliminary market engagement meeting. The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's. Please contact katie.noonan@nhs.net or marie.graney1@nhs.net to register your interest in tendering for this framework. Please indicate which products your company is planning to bring to market in your response.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-05936a
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/008310-2026
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£37,954,000 £10M-£100M
Lots Value
£37,954,000 £10M-£100M
Awards Value
£25,881,000 £10M-£100M
Contracts Value
£25,881,000 £10M-£100M

Notice Dates

Publication Date
30 Jan 20266 months ago
Submission Deadline
31 Oct 2025Expired
Future Notice Date
2 Oct 2025Expired
Award Date
25 Nov 20259 months ago
Contract Period
1 Feb 2026 - 30 Sep 2027 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active, Pending
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Postcode Area
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)
Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Supplier Information

Number of Suppliers
9
Supplier Names

ACCORD-UK LTD

AMAROX LIMITED

CELIX PHARMA LTD

DR REDDY'S LABORATORIES (UK) LIMITED

Farmak Pharmaceuticals UK Ltd

GLENMARK PHARMACEUTICALS EUROPE LIMITED

TEVA UK LIMITED

THORNTON & ROSS LIMITED

ZENTIVA PHARMA UK LIMITED

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...